<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5240">
  <stage>Registered</stage>
  <submitdate>28/10/2015</submitdate>
  <approvaldate>28/10/2015</approvaldate>
  <nctid>NCT02606734</nctid>
  <trial_identification>
    <studytitle>DyeVert Pilot Trial</studytitle>
    <scientifictitle>DyeVert Pilot Trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>TP-6463</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Coronary Angiography</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Coronary Angiography

Other: Treatment Arm - All subjects enrolled in the trial will use the DyeVert System.


Treatment: devices: Coronary Angiography
The DyeVert System will be used during coronary angiographic procedures which include: diagnostic only, diagnostic + PCI or PCI only cases.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Volume (Percentage) of Contrast Media (CM) Diverted (Saved) in a Total Procedure - The subject is exited from the study once they are discharged.</outcome>
      <timepoint>1 Day</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. The subject is indicated for a coronary angiogram or percutaneous coronary procedure

          2. The subject is = 18 years of age

          3. The subject (or subject's legal representative) is willing and able to provide
             appropriate informed consent.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Subject is undergoing a STEMI procedure

          2. The subject is female and currently pregnant

          3. In the investigator's opinion, the subject is not considered to be a suitable
             candidate</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/10/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>44</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2015</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Monash Health - Clayton</hospital>
    <postcode>3168 - Clayton</postcode>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>LÃ¼beck</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Osprey Medical, Inc</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to evaluate the usability characteristics of DyeVert during
      normal clinical use and to understand the amount of contrast media (CM) diverted from the
      subject and saved over a total angiographic procedure.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02606734</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>